| J9271 | Injection, pembrolizumab, 1 mg | 14,400 | $40 | $619.2K |
| J0897 | Injection, denosumab, 1 mg | 8,820 | $20 | $158.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 380 | $130 | $48.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 490 | $100 | $46.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 600 | $70 | $39.1K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 170 | $140 | $23.4K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 23,250 | $1 | $23.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 220 | $100 | $20.4K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 3,000 | $10 | $18K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 290 | $50 | $13.9K |